Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis.
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2014
Price : $35 *
At a glance
- Drugs Colchicine (Primary)
- Indications Pericarditis
- Focus Therapeutic Use
- Acronyms CORP2
- 18 Apr 2014 New trial record
- 30 Mar 2014 Primary endpoint 'Disease-recurrence-rate' has been met.
- 30 Mar 2014 Results published in the Lancet.